During the BSACI 2014 Meeting we filmed the session ‘Omalizumab – when it’s not for asthma’ and made it into a webinar which you can access below. 

In this session there are three presentations, each one can be accessed by clicking on ‘view mobile.’ 

1. There is a pro/con debate on whether Omalizumab should be the next option for antihistamine in unresponsive chronic urticaria. An interesting debate given by Dr Clive Grattan, Dermatologist who is pro the use of Omalizumab versus Dr Sinisa Savic who is not convinced and has said that more evidence is needed on the long term use of Omalizumab when treating those with unresponsive chronic urticaria. 26mins. 

2. The presentation on ‘Omalizumab in nasal polyposis’ is given by Professor Dr Philippe Gevaert. 20mins. 

3. ‘The role of Omalizumab in the treatment of food allergy’ presented by Professor Gideon Lack who is Head of the Children’s Allergy Service at Guy’s and St. Thomas’ NHS Trust and Professor of Paediatric Allergy at King’s College London. 37mins. 

Alternatively you can view the webinars on you tube by clicking the links below. 

Pro/Con: Omalizumab should be the next option for antihistamine - unresponsive chronic urticaria 

If you would like to view the webinars in the primary care resources page under E learning please click here.

Latest News Headlines


Become a BSACI Member...

GPs, Nurses, Allergy Specialists, Dieticians, Generalists

Join BSACI to receive the regular BSACI Allergy Update, have online access to the monthly journal 'Clinical & Experimental Allergy’, download our popular guidelines and a discount to the BSACI Annual Meeting.

Join Now